![]() |
JOURNAL TOOLS |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |

YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
CASE REPORT
Minerva Ginecologica 2000 December;52(12):521-6
Copyright © 2000 EDIZIONI MINERVA MEDICA
language: Italian
Endometrial carcinoma during tamoxifen therapy. A case report
Valenzano Menada M., Corticelli A., Giannesi A., Nicoletti L., Podestà M., Rissone R., Fulcheri E.
Tamoxifen is a non-steroid estrogenic antagonist, used in post-surgical therapy of breast cancer. It interferes with endocrinous promotion of breast cancer. Tamoxifen could determine endometrial, even carcinomatous, alterations.
The case of a postmenopausal patient surgically treated for breast cancer and successively treated with tamoxifen (20 mg/die), is reported.
She underwent ultrasonographic and hysterosonographic endometrial evaluation and finally a hysterectomy with bilateral annessiectomy.
This case seems to confirm tamoxifen possible carcinogenical effects on the endometrium.